Patient-Oriented Eczema Measure (POEM), a core instrument to measure symptoms in clinical trials: a Harmonising Outcome Measures for Eczema (HOME) statement

Background: The Harmonising Outcome Measures for Eczema (HOME) initiative has defined four core outcome domains for a core outcome set (COS) to be measured in all atopic eczema (AE) trials to ensure cross-trial comparison: clinical signs, symptoms, quality of life and longterm control. Objectives:...

Full description

Bibliographic Details
Main Authors: Spuls, Ph.I., Gerbens, L.A.A., Simpson, E., Apfelbacher, C.J., Chalmers, J.R., Thomas, K.S., Prinsen, C.A.C., Kobyletzki, L.B. von, Singh, J.A., Williams, Hywel C., Schmitt, J.
Format: Article
Published: Wiley 2017
Online Access:https://eprints.nottingham.ac.uk/39586/
_version_ 1848795870636539904
author Spuls, Ph.I.
Gerbens, L.A.A.
Simpson, E.
Apfelbacher, C.J.
Chalmers, J.R.
Thomas, K.S.
Prinsen, C.A.C.
Kobyletzki, L.B. von
Singh, J.A.
Williams, Hywel C.
Schmitt, J.
author_facet Spuls, Ph.I.
Gerbens, L.A.A.
Simpson, E.
Apfelbacher, C.J.
Chalmers, J.R.
Thomas, K.S.
Prinsen, C.A.C.
Kobyletzki, L.B. von
Singh, J.A.
Williams, Hywel C.
Schmitt, J.
author_sort Spuls, Ph.I.
building Nottingham Research Data Repository
collection Online Access
description Background: The Harmonising Outcome Measures for Eczema (HOME) initiative has defined four core outcome domains for a core outcome set (COS) to be measured in all atopic eczema (AE) trials to ensure cross-trial comparison: clinical signs, symptoms, quality of life and longterm control. Objectives: The aim of this paper is to report on the consensus process that was used to select the core instrument to consistently assess symptoms in all future AE trials. Methods: Following the HOME roadmap, two systematic reviews were performed which identified three instruments that had sufficient evidence of validity, reliability, and feasibility to be considered for the final COS. Results: At the 4th international HOME meeting there was broad consensus among all stakeholders that the Patient-Oriented Eczema Measure (POEM) should be used as the core instrument (87.5% agreed, 9.4% unsure, 3.1% disagreed). Conclusions: All relevant stakeholders are encouraged to use POEM as the chosen instrument to measure the core domain of symptoms in all future AE clinical trials. Other instruments of interest can be used in addition to POEM.
first_indexed 2025-11-14T19:38:58Z
format Article
id nottingham-39586
institution University of Nottingham Malaysia Campus
institution_category Local University
last_indexed 2025-11-14T19:38:58Z
publishDate 2017
publisher Wiley
recordtype eprints
repository_type Digital Repository
spelling nottingham-395862020-05-04T19:58:13Z https://eprints.nottingham.ac.uk/39586/ Patient-Oriented Eczema Measure (POEM), a core instrument to measure symptoms in clinical trials: a Harmonising Outcome Measures for Eczema (HOME) statement Spuls, Ph.I. Gerbens, L.A.A. Simpson, E. Apfelbacher, C.J. Chalmers, J.R. Thomas, K.S. Prinsen, C.A.C. Kobyletzki, L.B. von Singh, J.A. Williams, Hywel C. Schmitt, J. Background: The Harmonising Outcome Measures for Eczema (HOME) initiative has defined four core outcome domains for a core outcome set (COS) to be measured in all atopic eczema (AE) trials to ensure cross-trial comparison: clinical signs, symptoms, quality of life and longterm control. Objectives: The aim of this paper is to report on the consensus process that was used to select the core instrument to consistently assess symptoms in all future AE trials. Methods: Following the HOME roadmap, two systematic reviews were performed which identified three instruments that had sufficient evidence of validity, reliability, and feasibility to be considered for the final COS. Results: At the 4th international HOME meeting there was broad consensus among all stakeholders that the Patient-Oriented Eczema Measure (POEM) should be used as the core instrument (87.5% agreed, 9.4% unsure, 3.1% disagreed). Conclusions: All relevant stakeholders are encouraged to use POEM as the chosen instrument to measure the core domain of symptoms in all future AE clinical trials. Other instruments of interest can be used in addition to POEM. Wiley 2017-04 Article PeerReviewed Spuls, Ph.I., Gerbens, L.A.A., Simpson, E., Apfelbacher, C.J., Chalmers, J.R., Thomas, K.S., Prinsen, C.A.C., Kobyletzki, L.B. von, Singh, J.A., Williams, Hywel C. and Schmitt, J. (2017) Patient-Oriented Eczema Measure (POEM), a core instrument to measure symptoms in clinical trials: a Harmonising Outcome Measures for Eczema (HOME) statement. British Journal of Dermatology, 176 (4). pp. 979-984. ISSN 1365-2133 http://onlinelibrary.wiley.com/doi/10.1111/bjd.15179/abstract doi:10.1111/bjd.15179 doi:10.1111/bjd.15179
spellingShingle Spuls, Ph.I.
Gerbens, L.A.A.
Simpson, E.
Apfelbacher, C.J.
Chalmers, J.R.
Thomas, K.S.
Prinsen, C.A.C.
Kobyletzki, L.B. von
Singh, J.A.
Williams, Hywel C.
Schmitt, J.
Patient-Oriented Eczema Measure (POEM), a core instrument to measure symptoms in clinical trials: a Harmonising Outcome Measures for Eczema (HOME) statement
title Patient-Oriented Eczema Measure (POEM), a core instrument to measure symptoms in clinical trials: a Harmonising Outcome Measures for Eczema (HOME) statement
title_full Patient-Oriented Eczema Measure (POEM), a core instrument to measure symptoms in clinical trials: a Harmonising Outcome Measures for Eczema (HOME) statement
title_fullStr Patient-Oriented Eczema Measure (POEM), a core instrument to measure symptoms in clinical trials: a Harmonising Outcome Measures for Eczema (HOME) statement
title_full_unstemmed Patient-Oriented Eczema Measure (POEM), a core instrument to measure symptoms in clinical trials: a Harmonising Outcome Measures for Eczema (HOME) statement
title_short Patient-Oriented Eczema Measure (POEM), a core instrument to measure symptoms in clinical trials: a Harmonising Outcome Measures for Eczema (HOME) statement
title_sort patient-oriented eczema measure (poem), a core instrument to measure symptoms in clinical trials: a harmonising outcome measures for eczema (home) statement
url https://eprints.nottingham.ac.uk/39586/
https://eprints.nottingham.ac.uk/39586/
https://eprints.nottingham.ac.uk/39586/